Based on these limitations, our findings on the prognostic role and therapeutic implications of subventricular zone involvement in glioma WHO grade 2 warrant evaluation in prospective cohorts which consider novel prognostic markers such as CDKN2A/2B deletion. The gene discussed is CDKN2A; the disease is central nervous system cancer.